Go Pro
→ The $15 Gold Fund That Pays Up to $1,152/Month (From Investors Alley) (Ad)tc pixel
NASDAQ:INGN

Inogen Q2 2026 Earnings Report

Inogen logo
$6.84 +0.13 (+1.94%)
As of 12:38 PM Eastern
This is a fair market value price provided by Massive. Learn more.
ProfileEarnings HistoryForecast

Inogen EPS Results

Actual EPS
N/A
Consensus EPS
-$0.17
Beat/Miss
N/A
One Year Ago EPS
N/A

Inogen Revenue Results

Actual Revenue
N/A
Expected Revenue
$95.23 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Inogen Announcement Details

Quarter
Q2 2026
Date
8/6/2026
Time
After Market Closes
Conference Call Date
Thursday, August 6, 2026
Conference Call Time
5:00PM ET

Conference Call Resources

Inogen Earnings Headlines

Inogen (NASDAQ:INGN) Share Price Passes Below 200 Day Moving Average - Time to Sell?
July 29, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30927702
Inogen to Report Second Quarter 2026 Financial Results on August 6, 2026
July 16, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260716850828/en/Inogen-to-Report-Second-Quarter-2026-Financial-Results-on-August-6-2026/
They Crashed the Dollar 40% Before. It's Happening Again.
In 1985, world powers deliberately drove the dollar lower in a coordinated deal that drained everyday savers. Insiders are now calling a potential repeat the 'Mar-a-Lago Accord' - using tariffs and currency pressure to push the dollar down by design in 2026. Your IRA and retirement savings could be quietly eroded before you act. A free information kit outlines three strategies to help protect your wealth before the shift takes hold.tc pixel
August 4 at 1:00 AM  |  Priority Gold (Ad)
Inogen Appoints New Chief Operating Officer for Growth
July 9, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/INGN-Q/pressreleases/3106716/inogen-appoints-new-chief-operating-officer-for-growth/
Inogen Announces the Appointment of Andy Reding as Chief Operating Officer
July 1, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260701409894/en/inogen-announces-the-appointment-of-andy-reding-as-chief-operating-officer/
Inogen Shareholders Approve Expanded Equity Incentive Plan
June 11, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/inogen-shareholders-approve-expanded-equity-incentive-plan?utm_source=marketbeat.com&utm_medium=referral
See More Inogen Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Inogen? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Inogen and other key companies, straight to your email.

About Inogen

Inogen (NASDAQ:INGN). (NASDAQ: INGN) is a medical device company specializing in the development, manufacture and marketing of innovative oxygen therapy solutions. The company’s core focus is on portable oxygen concentrators (POCs) designed to support patients with chronic respiratory conditions such as chronic obstructive pulmonary disease (COPD). Inogen’s offerings aim to provide users with mobility and independence by reducing reliance on traditional compressed-gas cylinders and enabling oxygen therapy on the go.

Inogen’s flagship product line, including the Inogen One family of portable oxygen concentrators, leverages proprietary flow technology to deliver continuous and pulse-dose oxygen. These devices are engineered to be lightweight, battery-powered and FAA-approved for in-flight use, addressing both clinical efficacy and user convenience. The company also offers supporting accessories such as batteries, chargers and carrying cases to enhance patient experience and ensure uninterrupted oxygen delivery.

Founded in 2001 and headquartered in Goleta, California, Inogen has obtained regulatory clearance from the U.S. Food and Drug Administration (FDA) and CE Mark approval for distribution in Europe. The company serves a global customer base through direct-to-consumer sales channels as well as partnerships with home healthcare providers and distributors across North America, Europe and parts of the Asia-Pacific region. Inogen is led by President and Chief Executive Officer Scott Wilkinson, under whose leadership the company has invested in research and development to expand its product portfolio and support emerging digital health initiatives.

View Inogen Profile
Earnings Tools